Ameritas Investment Partners, Inc. Concert Pharmaceuticals, Inc. Transaction History

Ameritas Investment Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$3.77 - $5.24 $8,791 - $12,219	-2,332 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$7.8 - $11.52 $6,279 - $9,273	805 Added 52.72%	2,332 $23,000
Q4 2017 Feb 14, 2018	BUY	$13.96 - $29.05 $4,746 - $9,877	340 Added 28.64%	1,527 $40,000
Q2 2017 Aug 15, 2017	BUY	N/A	1,187	1,187 $17,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.